Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 2
2000 3
2001 1
2002 2
2003 3
2004 4
2005 5
2006 4
2007 3
2008 3
2009 2
2011 1
2012 2
2013 3
2014 1
2015 1
2016 3
2017 1
2018 3
2019 5
2020 7
2021 5
2022 7
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline.
Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, Gaga M, Kellermeyer L, Khurana S, Knight S, McDonald VM, Morgan RL, Ortega VE, Rigau D, Subbarao P, Tonia T, Adcock IM, Bleecker ER, Brightling C, Boulet LP, Cabana M, Castro M, Chanez P, Custovic A, Djukanovic R, Frey U, Frankemölle B, Gibson P, Hamerlijnck D, Jarjour N, Konno S, Shen H, Vitary C, Bush A. Holguin F, et al. Among authors: diver s. Eur Respir J. 2020 Jan 2;55(1):1900588. doi: 10.1183/13993003.00588-2019. Print 2020 Jan. Eur Respir J. 2020. PMID: 31558662 Free article.
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial.
Diver S, Khalfaoui L, Emson C, Wenzel SE, Menzies-Gow A, Wechsler ME, Johnston J, Molfino N, Parnes JR, Megally A, Colice G, Brightling CE; CASCADE study investigators. Diver S, et al. Lancet Respir Med. 2021 Nov;9(11):1299-1312. doi: 10.1016/S2213-2600(21)00226-5. Epub 2021 Jul 10. Lancet Respir Med. 2021. PMID: 34256031 Clinical Trial.
Cough and Eosinophilia.
Diver S, Russell RJ, Brightling CE. Diver S, et al. J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1740-1747. doi: 10.1016/j.jaip.2019.04.048. J Allergy Clin Immunol Pract. 2019. PMID: 31279462 Review.
Letter from the UK.
Diver S, Brightling C, Ohri C. Diver S, et al. Respirology. 2020 Dec;25(12):1323-1324. doi: 10.1111/resp.13957. Epub 2020 Oct 19. Respirology. 2020. PMID: 33078495 Free article. No abstract available.
Big asthma data: getting bigger and more beautiful?
Diver S, Brightling CE. Diver S, et al. Thorax. 2018 Apr;73(4):311-312. doi: 10.1136/thoraxjnl-2017-211148. Epub 2017 Dec 29. Thorax. 2018. PMID: 29288213 No abstract available.
Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.
Diver S, Haldar K, McDowell PJ, Busby J, Mistry V, Micieli C, Brown V, Cox C, Yang F, Borg C, Shrimanker R, Ramsheh MY, Hardman T, Arron J, Bradding P, Cowan D, Mansur AH, Fowler SJ, Lordan J, Menzies-Gow A, Robinson D, Matthews J, Pavord ID, Chaudhuri R, Heaney LG, Barer MR, Brightling C; Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium). Diver S, et al. Allergy. 2022 Nov;77(11):3362-3376. doi: 10.1111/all.15425. Epub 2022 Jul 15. Allergy. 2022. PMID: 35778780 Free article.
New and emerging drug treatments for severe asthma.
Diver S, Russell RJ, Brightling CE. Diver S, et al. Clin Exp Allergy. 2018 Mar;48(3):241-252. doi: 10.1111/cea.13086. Epub 2018 Feb 13. Clin Exp Allergy. 2018. PMID: 29315966 Review.
Corticosteroid Responsiveness Following Mepolizumab in Severe Eosinophilic Asthma-A Randomized, Placebo-Controlled Crossover Trial (MAPLE).
Yang F, Busby J, Heaney LG, Pavord ID, Brightling CE, Borg K, McDowell JP, Diver SE, Shrimanker R, Bradding P, Shepherd M, Chaudhuri R; Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium). Yang F, et al. Among authors: diver se. J Allergy Clin Immunol Pract. 2022 Nov;10(11):2925-2934.e12. doi: 10.1016/j.jaip.2022.06.050. Epub 2022 Jul 19. J Allergy Clin Immunol Pract. 2022. PMID: 35863669 Free article. Clinical Trial.
72 results